Kathrine Meyers, DrPH, MPP, is an Instructor of Clinical Investigation at The Rockefeller University and Director of the China AIDS Initiative at the Aaron Diamond AIDS Research Center. She earned her doctorate of public health from the Department of Sociomedical Sciences at Columbia University Mailman School of Public Health in 2011 and a Master in public policy from Harvard University Kennedy School of Government in 2002.
As the Director of the China AIDS Initiative she oversees a portfolio of HIV prevention projects in China. From 2005-2012 she managed an integrated prevention of maternal-to-child transmission program in Yunnan Province documenting the efficacy, acceptability, and feasibility of using combination antiretroviral therapy among all HIV-infected pregnant women to maximize maternal health and achieve a vertical transmission rate of less than 2%. She also advocated for an integrated prevention of mother-to-child transmission approach that introduced screening for syphilis, hepatitis, and HIV for all pregnant women as a part of antenatal care in Yunnan. The approach has since been scaled up into Chinese national policy.
Since 2012 she has become involved in preparing for and implementing biomedical HIV prevention trials. This has included conducting epidemiological studies of HIV incidence among cohorts of men who have sex with men in China, studies of acceptability of long-acting injectable PrEP among men who have sex with men in China and New York, and a study investigating key structural, behavioral and social dynamics related to the implementation of long-acting injectable PrEP. She is serving as a member of the Protocol Team for a suite of prevention trials of the investigational integrase inhibitor, Cabotegravir, in China, and is leading the effort to integrate social and behavioral aspects into these trials. Finally, she is spearheading the community engagement effort among men who have sex with men and transgender women in China to facilitate the successful implementation of these trials in trial sites across China. In NY she conducts behavioral and social science research among participants and staff in HIV prevention and treatment trials to capture lessons learned from those who experience investigational products first in order to support planning for rapid implementation of newly-approved HIV prevention and treatment modalities.